1-Jahres-Chart
5-Tage-Chart
| Realtime | Geld | Brief | Zeit |
|---|---|---|---|
| 0,725 | 0,770 | 30.04. |
- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| Di | ARRAIL GROUP (06639): NEXT DAY DISCLOSURE RETURNS | - | HKEx | ||
| 18.04. | ARRAIL GROUP (06639): NEXT DAY DISCLOSURE RETURNS | - | HKEx | ||
| 11.04. | ARRAIL GROUP (06639): NEXT DAY DISCLOSURE RETURNS | 1 | HKEx | ||
| 03.04. | ARRAIL GROUP (06639): NEXT DAY DISCLOSURE RETURNS | - | HKEx | ||
| 27.03. | ARRAIL GROUP (06639): NEXT DAY DISCLOSURE RETURNS | 1 | HKEx | ||
| 20.03. | ARRAIL GROUP (06639): NEXT DAY DISCLOSURE RETURNS | 1 | HKEx | ||
| 12.03. | ARRAIL GROUP (06639): NEXT DAY DISCLOSURE RETURNS | - | HKEx | ||
| 11.03. | ARRAIL GROUP (06639): VOLUNTARY ANNOUNCEMENT - SHARE REPURCHASE PLAN UNDER THE GENERAL MANDATE | - | HKEx | ||
| 26.02. | ARRAIL GROUP (06639): NEXT DAY DISCLOSURE RETURNS | 1 | HKEx | ||
| 06.02. | ARRAIL GROUP (06639): NEXT DAY DISCLOSURE RETURNS | - | HKEx | ||
| 29.01. | ARRAIL GROUP (06639): NEXT DAY DISCLOSURE RETURNS | - | HKEx | ||
| 23.01. | ARRAIL GROUP (06639): (REVISED) NEXT DAY DISCLOSURE RETURNS | 1 | HKEx | ||
| 22.01. | ARRAIL GROUP (06639): NEXT DAY DISCLOSURE RETURNS | 1 | HKEx | ||
| 03.01. | ARRAIL GROUP (06639): LIST OF DIRECTORS AND THEIR ROLES AND FUNCTIONS | 1 | HKEx | ||
| 03.01. | ARRAIL GROUP (06639): PASSING AWAY OF EXECUTIVE DIRECTOR | - | HKEx | ||
| 03.01. | ARRAIL GROUP (06639): NEXT DAY DISCLOSURE RETURNS | - | HKEx | ||
| 27.12.23 | ARRAIL GROUP (06639): 2023 INTERIM REPORT | 1 | HKEx | ||
| 05.12.23 | ARRAIL GROUP (06639): NEXT DAY DISCLOSURE RETURNS | - | HKEx | ||
| 29.11.23 | FAST NEWS: Arrail Group swings to black on post-Covid rebound | 1 | Bamboo Works | ||
| 28.11.23 | ARRAIL GROUP (06639): INTERIM RESULTS ANNOUNCEMENT FOR THE SIX MONTHS ENDED SEPTEMBER 30, 2023 | 1 | HKEx |
Seite:
1 2 Weiter >>
22 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| MEDTRONIC | 75,48 | +0,39 % | Medtronic Plc-Aktie läuft heute schlechter (75,3286 €) | Der Anteilsschein von Medtronic Plc notiert am Dienstag etwas leichter. Das Wertpapier kostete zuletzt 80,46 US-Dollar. Heute hat sich an der US-amerikanischen Börse der Anteilsschein von Medtronic... ► Artikel lesen | |
| HCA HEALTHCARE | 289,30 | +2,44 % | HCA Healthcare, Inc. Q1 Profit Increases, beats estimates | WASHINGTON (dpa-AFX) - HCA Healthcare, Inc. (HCA) released a profit for its first quarter that increased from the same period last year and beat the Street estimates.The company's earnings came... ► Artikel lesen | |
| AMEDISYS | 84,50 | +0,60 % | Amedisys (AMED) Q1 Earnings Surpass Estimates, Margins Rise | ||
| LANTHEUS | 62,62 | +0,45 % | Lantheus Q1 2024 Earnings Preview | ||
| ENVISTA | 19,100 | +1,06 % | Envista shares drop after earnings miss | ||
| CAREDX | 7,586 | +8,56 % | CareDx, Inc. - S-8, Securities to be offered to employees in employee benefit plans | ||
| GT BIOPHARMA | 3,120 | +4,00 % | GT Biopharma, Inc. - 8-K, Current Report | ||
| SYNEOS HEALTH | 40,000 | 0,00 % | Research and Markets: 2024 Biopharmaceutical Sponsor Interaction with Clinical Site Networks Pulse Report Featuring IQVIA, ICON, Parexel, Fortrea (formerly Labcorp), PPD/Thermo Fisher, and Syneos Health - ResearchAndMarkets.com | The "2024 Biopharmaceutical Sponsor Interaction with Clinical Site Networks Pulse Report" has been added to ResearchAndMarkets.com's offering.
The biopharmaceutical clinical development landscape... ► Artikel lesen | |
| CARMAT | 3,035 | +1,17 % | CARMAT: Availability of the 2023 Universal Registration Document | Regulatory News:
CARMAT (FR0010907956, ALCAR), designer and developer of the world's most advanced total artificial heart, aiming to provide a therapeutic alternative for people suffering from... ► Artikel lesen | |
| CHEMOMETEC | 39,220 | -1,36 % | Chemometec A/S: Clarification of guidance for revenue and lower than expected operating profit in the 2023/24 financial year | ANNOUNCEMENT NO. 261 Clarification of guidance for revenue and lower than expected operating profit in the 2023/24 financial year According to the preliminary figures, revenue in the third quarter... ► Artikel lesen | |
| HAMILTON THORNE | 0,925 | +0,54 % | Bloom Burton & Co. Inc.: Hamilton Thorne Ltd. to Present at the 2024 Bloom Burton & Co. Healthcare Investor Conference | Beverly, Massachusetts--(Newsfile Corp. - April 10, 2024) - Hamilton Thorne Ltd. (TSX: HTL) (OTC Pink: HTLZF), Hamilton Thorne Ltd. a leading provider of precision instruments, laboratory equipment... ► Artikel lesen | |
| DEVYSER DIAGNOSTICS | 8,280 | -0,48 % | Devyser Diagnostics AB: Devyser Diagnostics publishes year-end report for January to December 2023 | "Devyser is able to report strong sales growth and record high gross margins for the fourth quarter. During the quarter, Devyser continued to demonstrate the competitiveness of its products by winning... ► Artikel lesen | |
| POLAREAN IMAGING | 0,014 | 0,00 % | Polarean Imaging PLC - U.S. Patent granted for Xenon MRI | ||
| PROCEPT BIOROBOTICS | 60,61 | +14,40 % | Earnings call: PROCEPT BioRobotics sees 83% revenue surge in Q1 2024 | ||
| MOBILE-HEALTH NETWORK SOLUTIONS | 21,430 | 0,00 % | Mobile-health Retreats on Opening New Pharmacy |
ARRAIL GROUP LTD gehört der Branche Gesundheitswesen an. Mit einer aktuellen Kursveränderung von -0,015 (-2,03 %) liegt der Kurs bei 0,725 Euro.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und
